The companies are doling out money to nonprofits, in a move that could potentially be building goodwill ahead of the massive legal battle the industry is about to face. Meanwhile, KHN takes a look at how competition in the early days of the opioid push helped shape the companies' strategies.

from Kaiser Health News https://ift.tt/2LJEUGR

Related Posts:

0 comments:

Post a Comment

Popular Posts